A Predictive model for liver disease progression based on logistic regression algorithm by Shaker Abdalrada, Ahmad et al.
Periodicals of Engineering and Natural Sciences   ISSN 2303-4521 
Vol. 7, No. 3, September 2019, pp.1255-1264 
Available online at: http://pen.ius.edu.ba 
 
 1255 
A predictive model for liver disease progression based on logistic 
regression algorithm 
Ahmad Shaker Abdalrada
1
, Omar Hashim Yahya
2
, Abdul Hadi M. Alaidi
3
, Nasser Ali Hussein
4
, Haider 
TH. Alrikabi
5
, Tahsien Al-Quraishi
6 
1Department of Software Engineering, Faculty of Computer Science and Infromation Technology, Wasit University, Iraq.   
2North Technical University, Iraq. 
3Department of Software Engineering, Faculty of Computer Science and Infromation Technology, Wasit University, Iraq.   
 4Department of Computers, College of Education for Pure Sciences, Wasit University, Iraq.   
5Department of Electrical Engineering, Faculty of Engineering, Wasit University, Iraq. 
 6Department of Software Engineering, Faculty of Computer Science and Infromation Technology, Wasit University, Iraq.   
 
 
Article Info  ABSTRACT  
 
Received March 13, 2019 
 Liver disease counts to be one of the most prevalent diseases in the 
worldwide. Therefore, this paper is  aim to address the problem of predicting 
liver disease progression. As the existing predictive models focus on 
predicting the label of disease; the probability of developing the disease is still 
obscure. This paper, therefore, has proposed a model to predict the probability 
occurrence of liver diseases. The proposed predictive model used logistic 
regression abilities to predict the probability of liver disease occurrence. ILPD 
dataset was used to analyze the performance of the model. The predictive 
model has shown outstanding performance with a prediction accuracy rate of 
72.4%, the sensitivity of 90.3%, the specificity of 78.3 %, Type I Error of 9.7 
%, Type II Error of 21.7 %, and ROC of 0.758%. The model has furthermore 
confirmed the feasibility of the laboratory tests such as as (Age; Direct 
Bilirubin (DB), Alamine_Aminotransferase (SGPT), Total_Protiens (TP), 
Albumin (ALB)) to predict the disease progression. The predictive model will 
be helpful to patients and doctors to realize the progression of the disease and 
make a suitable timely intervention. 
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1. INTRODUCTION 
Liver disease (hepatic disease) is any disease that harmfully affects the regular, healthy performance of the liver. 
It considers as a significant risk factor for mortality and morbidity rates, which significantly impacts the patient 
quality of life. For example, a study that followed 11,448 subjects for 5 years showed that the incidence of a 
disease was 12% (n = 1,418) [1].  Another cohort study followed  77,425 free of liver disease subjects for 4.5 
years,  10,340 of them have developed the disease [2]. In general, more than 75% of liver tissue requires to be 
affected before the function of the liver is decreased [3].  There are several symptoms indicts to liver diseases 
such as fatigue, jaundice, sickness, puke, pain in the back, and abdominal, fluid in the abnormal cavity, general 
itching, and  weight loss [4]. Many factors such as genes, viruses, drugs, snuffing of dangerous gases, alcohol, 
eating of contaminated food,  and pickles are contributed in developing the disease[5]. Obesity, Cholesterol or 
triglycerides are also related to liver damage. Chemicals and minerals, or infiltrated by abnormal cells, such as 
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cancer cells are also could cause damage to the Liver Tissue [3]. It is therefore essential to perform a timely 
diagnosis of the disease to prevent the occurrence or decrease the possible risks consequences. 
Though there have been extensive researches done to provide a definitive therapeutic approach for liver diseases, 
however there is no definitive method to predict the disease progression has been developed so far. Moreover, the 
efficacy of antiviral treatment to prevent the progression of disease in patients with chronic hepatitis B and 
cirrhosis or advanced fibrosis is obscure [6]. Many studies have been carried out to diagnose liver disease using 
blood tests combined with various risk factors [7-14]. Although there have been some excellent results from these 
models, the disease's progression remains obscure. This study, therefore, aims to handle this gap. This has a 
significant impact on health-care specialists to provide timely intervention and increase patient awareness. 
Machine learning is one of the fields of computer science, employ algorithms of computer to find patterns in data, 
as well as help in predicting various outcome depend on the used data [15].  Such algorithms have appeared as a 
reliable methods for estimation and decision-making in the various fields of real life [16]. As a result of the 
availability of medical data, such algorithms have a significant contribution to medical decision making [17, 18]. 
Using machine learning capabilities to develop an efficient predictive model would serve as valuable assistance to 
identify the disease and make a real-time effective medical decision. 
In this paper, we develop a seamless model that will help to predict the occurrence of liver disease. The proposed 
predictive model is based on the logistic regression method. The model predicts the likelihood of liver disease 
occurrence based on blood tests. Our main contributions are as follow: 
 Develop a predictive model can predict the probability of liver disease occurrence. 
 Investigate the significance of the included tests in the predicting of disease. 
 We analyzed the performance of the proposed predictive model using ILPD dataset.  
The outline of this study is as follows: Section 2 reviews the existing related works. Section 3 explains the 
proposed predictive model. Analysis of the proposed predictive model, results are presented in Section 4. At the 
end, we present the conclusion in section 5. 
2. Related Works  
In this section, relevant prior works about liver disease prediction are reviewed as presented in Table 1.  
Table 1: Reviews of the different works of diagnosing Liver's disease. 
Study Prediction of liver disease 
Categories Occurrence Probability 
Vijayarani, Dhayanand [7] Yes NO 
Dhamodharan [8] Yes NO 
Karthik, Priyadarishini [9] Yes NO 
Nahar, Ara [10]   Yes NO 
Kumar, Sahoo [11] Yes NO 
Wu, Yeh [12] Yes NO 
Hashem and Mabrouk [13] Yes NO 
Nagaraj and Sridhar [14] Yes NO 
Vijayarani, Dhayanand [7] have compared the performance of classification algorithms to predict liver diseases. 
The compared algorithms in this work were Naïve Bayes (NB) and support vector machine (SVM).  The 
experimental results showed that the SVM is a superior classifier than the Naïve Bayes to predicting the liver 
diseases. “Another work has been proposed to predict the three major types of the disease such as Liver cancer, 
Hepatitis, and Cirrhosis using the notable symptoms [8]”. To achieve this study Naïve Bayes and FT Tree 
approaches were used to expect the types of the disease. The experiment’s result showed that Naïve Bayes has 
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outstanding the FT Tree algorithm in the accuracy measure. Karthik, Priyadarishini [9] applied a soft computing 
method to identify the liver disease. The authors have applied the method in three phases. In the first phase, the 
Artificial Neural Network (ANN) classification algorithm was used to classify liver disease. In the second phase, 
the rules of classification were produced using Learn by Example (LEM) algorithm implemented in rough set rule 
induction whereas the third phase was used to identify the types of liver disease using fuzzy rules. “Different 
work by [10]  has proposed to measure the performance of many decision tree (DT) methods then compare their 
achievement in predicting liver disease. The methods that used in this study were J48, LMT, Random Forest (RF), 
Random tree (RT), REPTree, Decision Stump (DS), and Hoeffding Tre. The result of the comparison showed that 
DS overcome the other used methods with the high accuracy. “Kumar, Sahoo [11] has also proposed a rule-based 
model combine with various machine learning techniques to predict the diverse types of the disease. The 
techniques were Rule Induction (RI), Naive Bayes (NB), Decision Tree (DT), Support Vector Machine (SVM), 
and Artificial Neural Network (ANN). “The proposed model combines with decision tree (DT) showed better 
result among all the other methods (RI, SVM, ANN, and NB). “Another work by [12] developed and compared 
the performance of different machine learning methods in order to predict Fatty liver disease (FLD). “The 
evaluated methods were (ANN), (RF), (NB), and logistic regression (LR)”. The result of the study revealed that 
(RF) showed outstanding result than other methods. “Hashem and Mabrouk [13] evaluate the performance of 
Support vector machine to classify patients of the liver disease using two datasets with diverse  tests combinations 
such as SGOT, SGPT, and Alkaline Phosphates”. A hybrid model has proposed [14] by to diagnose liver disease 
known as  NeuroSVM model using SVM and feed-forward artificial neural network (ANN). 
Despite the excellent performance of the proposed models in the literature [7-12, 14], these models, however, did 
not handle the problem of predicting the probability of LIVER DISEASE occurrence. Also, the models are more 
general, where they have proposed to predict the categories of the disease (e.g., healthy, or patient). More specific, 
they did not show the progress of the disease of each patient. 
3. The Framework of the Predictive Model 
This section illustrates the predictive model to predict of the probability of liver disease incidence. Figure 1 
elaborates the steps of building the predictive model in this study. 
 
 
Figure 1: A graphical explanation of the predictive model. 
 
In this section, we introduce the predictive model that we proposed to predict the probability of liver disease 
occurrence . The model is readily to run with various platforms and tools such as the R language. It can provide 
both specialists and patients with a clear vision about the disease progress. Consequently, knowing the degree of 
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the disease progress facilitates the planning of timely intervention as well as creates greater awareness about the 
disease’s risk.   
In order to build our proposed predictive model, we have exploited the capabilities of logistic regression. As the 
general formula of logistic regression in terms of sigmoid function can be expressed as follows  [19]: 
   
 
        
        
Where   represent the probability of an event occurrence (dependent variable); whereas    is the linear 
combination function of the independent variables.    can also be expressed as follows: 
                          (2). 
Where    denotes to the expected mean value of   when the      ;    represents the number of the independent 
variables;      refres to the regression coefficients of each independent variable. It is the value of influence for 
each independent variable on the probability of   value.    refers to the independent variables [20-22].  
By applying the linear combination function in equation (1) for the used tests as independent variables to 
determine an outcome (liver disease progress); the formula of the predictive model that computes the probability 
of occurrence of liver’s disease progress depending on the predictability of used tests can be written as below:  
   
 
                                                                                   
      
Where   represents the probability of occurrence of an outcome (liver’s disease progress) based on the 
selected independent variables.    indicates to the regression coefficients of each included blood test. As 
for (  ,   ,   ,   ,                   ) refer to the included tests (“Age , Gender ,Total Bilirubin (TB) , 
Direct Bilirubin (DB) , Alkaline Phosphatase (ALKPHOS) ,Alamine_Aminotransferase(SGPT), 
Aspartate Aminotransferase(SGOT), Total_Protiens(TP), Albumin, Ratio of Albumin and Globulin 
(A/G)”) respectively. The description of each blood test is presented in the dataset section. 
 
Table 2. The analysis of logistic regression for all tests. 
Test β P value Odds 
Ratio 
Confidence interval (%) 
Intercept  -3.605 0.000 0.027  
   (Age)  0.018 0.004 1.018 1.006- 1.031 
   (Gender M)  0.031 0.8 1.031 0 .654- 1.628 
   (Total Bilirubin)  0.011 0.8 1.011 0 .853 - 1.199 
    ( Direct Bilirubin) 0.45 0.05 1.568 0 .977- 2.517 
    (Alkaline Phosphatase) 0.001 0.1 1.001 1.000- 1.003 
    (Alamine_Aminotransferase) 0.012 0.01 1.012 1.002 - 1.022 
   (Aspartate Aminotransferase) 0.002 0.4 1.002 0 .996 - 1.009 
    (Total_Protiens) 0.927 0.01 2.528 1.197 - 5.339 
   (Albumin) -1.695 0.02 0.184 0 .042 - 0.795 
   (Albumin_and_Globulin_Ratio) 1.808 0.1 6.099 0 .652 - 57.063 
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Later, logistic regression was used to calculate the coefficients of the covariates. Table 2 presents the outcome of 
applying logistic regression using covariates as independent variables and liver disease as the dependent variable. 
As evident from Table 2, some of the covariates have a significant association with the disease (P < 0.05) and 
therefore, have been included in the predictive model whereas insignificant variables have been disregard. After 
that, logistic regression was used again to calculate the coefficients of the involved variables (showed significant 
association in table 2) as presented in table 3. 
Table 3. The analysis of logistic regression for the involved variables 
Test β P value Odds Ratio Confidence Interval (%) 
Intercept  -1.68 0.02 0.186  
   (Age)  0.019 0.003 1.019 1.006- 1.031 
    ( Direct Bilirubin) 0.55 0.001 1.728 1.229- 2.430 
    (Alamine_Aminotransferase) 0.016 0.000 1.016 1.008- 1.024 
    (Total_Protiens) 0.43 0.01 1.541 1.093- 2.173 
   (Albumin) -0.67 0.00 0.513 0.315- 0.837 
 
As presented in Table 3, the coefficients of    (Age) and     (Direct Bilirubin) were (    = 0.019; P = 0.003) and 
(   = 0.55; P =0.001) respectively. The coefficients of     (Alamine_Aminotransferase) and     (Total_Protiens) 
were (    = 0.016; P =0.00) and (    = 0.43; P = 0.01) respectively. As for    (Albumin) the coefficient was (      
= -0.67; P = 0.00).  
The outcomes of    (Age),    (Direct Bilirubin),    (Alamine_Aminotransferase) and     (Total_Protiens) tests 
showed positive   coefficient values, which indicated their positive influence on the disease occurrence. On the 
other hand, the    (Albumin) showed a negative   coefficient value, indicating it had a negative effect on the 
disease occurrence. Based on equation (3) and the outcomes in Table 3, the predictive model was built as follows:  
   
 
                                                                     
       
After constructing the predictive model of liver disease based on the significant association variables, if new tests 
from the clinic are gained, for example, it is possible to use the predictive model to calculate the probability of 
liver disease occurrence.  
The following cases are examples of applying the predictive model to determine the probability of liver’s disease.  
Assuming the following involving tests for patient A are (   (Age) = 65;    (Direct Bilirubin) = 0.1;    
(Alamine_Aminotransferase) = 16;     (Total_Protiens) = 6.8;    (Albumin) = 3.3);  Patient B are (   (Age) = 74; 
   (Direct Bilirubin) = 0.4;    (Alamine_Aminotransferase) = 22;     (Total_Protiens) = 8.1;    (Albumin) = 4.1) 
and  Patient C are (   (Age) = 45;    (Direct Bilirubin) = 0.2;    (Alamine_Aminotransferase)  = 21;     
(Total_Protiens) = 5.7;    (Albumin)  = 2.5).  
By applying equation (4) with the tests of the three patients, the probability of developing liver's disease of patient 
A can be calculated as follows: 
       
 
                                                                        
        
As for patient B, the probability of developing liver’s disease can be calculated as follows  
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Whereas the probability of patient C developing liver's disease can be calculated as follows  
       
 
                                                                        
        
4. The Evaluation of the Predictive Model 
We conducted an analysis and evaluation of the proposed predictive model. In this section, the dataset, 
experimental setup and the metrics used are presented. 
4.1 Experimental Setup 
All experiments were accomplished by SPSS version 20.0 (SPSS, Inc., Chicago, IL, USA) and R language on PC 
with Intel Core 5, CPU 3.4 GB, 16GB RAM running Windows 10 operating system. Various measures such as 
accuracy, sensitivity, specificity and confusion matrix measurements calculated to assess accomplishment of the 
predictive model. 
Following is the description of the evaluation measures used in the current paper: For validation, we employed 
10-fold cross-validation (CV) to obtain a balanced evaluation of the generalization error. The 10-fold cross-
validation (CV) divided the entire dataset into 10 sub-sets randomly: 9 sub-sets were employed for training stage 
(90%), and the remaining sub-set was exploited in testing stage (10%). This procedure is then repeated ten times 
with replacement in the tested folds. “The standard measurements such as accuracy, sensitivity, specificity, Type I 
Error and Type II Error were calculated to evaluate the performance of the predictive model”. 
4.2 Dataset 
In this study, a real well-known Indian Liver Patient Dataset (ILPD) used. ILPD is a public dataset existing in the 
Machine learning repository (UCI). The data collected in Andhra Pradesh region, India. ILPD contains 583 
instances with various tests as listed in table 4. The dependent variable was stated depend on these tests. As result 
416 cases were with liver disease and 167 cases were healthy. The information of the used data is presented in 
table 4. 
Table 4. ILPD description 
Test Description   
Age Age of the patient 
Gender  Male or Female 
TB  Total Bilirubin  
DB Direct Bilirubin 
ALKPHOS  Alkaline Phosphatase 
SGPT  Alanine Aminotransferase 
SGOT  Aspartate Aminotransferase 
TP Total of Proteins  
ALB Albumin 
A/G Ratio of Albumin and Globulin 
Disease status  Healthy or patient  
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4.3 Performance Metrics 
The area under the curve (AUC) which is also known as receiver operating characteristic curve (ROC) is used to 
assess the achievement of the predictive model for the current study. The ROC curve is an essential tool that is 
used for diagnose test evaluation. What follows below is a description of the evaluation measures applied in the 
current study: 
 Sensitivity: represents the number of participants correctly predicted with a positive disease. 
           
  
     
        
 
 Speciﬁcity: depicts the number of participants correctly diagnosed with a negative disease. 
            
  
     
      
 
 Accuracy: exposes the total number of participants correctly predicted with a positive and negative 
disease.  
         
      
              
       
 
 Type I Error (α): the probability of diagnosing patients into a control group.  
 
   
  
       
                      
 
 Type II Error: represents the probability of diagnosing control subjects with the patient group.  
        
  
       
                         
 
 
5. Result 
In this section, the experimental results and discussions are presented. Table 5 displays the confusion matrix of 
the predictive model. As is evident in the confusion matrix, the model has achieved predictive accuracy of 72.4%. 
The model has correctly predicted 381 patient out of 416 while 41 out of 167 healthy participants. This 
performance is achieved because of that all the included tests are significantly associated with the disease (P < 
0.05).  
 
Table5. Shows the confusion matrix 
Class Healthy Patient 
Healthy 126  41  
Patient 35  381  
The sensitivity achieved by the predictive model was 90.3 %, which refers to the number of patients that are 
correctly identified with a positive disease. In meanwhile, the obtained speciﬁcity by the model was 78.3 %. As 
for Type I Error, and Type II Error of the predictive model, they were 9.7 % and 21.7% respectively. This 
demonstrates that the model can be efficiently employed to predict the probability of liver disease occurrence.It is 
also possible to exploit such a model with different health conditions.  
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Table 6. The AUC of the Predictive Model. 
Area Under the Curve 
Test Result Variable(s): Predicted probability 
ROC Std. Errora Asymptotic Sig.
b
 Confidence interval (%) 
0.758 0 .020 0.000 0.719-0.797 
 
Figure 2. ROC curve of the Predictive Model 
Figure 2 clarifies the ROC curves of the predictive model and the details as listed in Table 6.As illustrated in 
Table 6, the ROC of the predictive model is 0.758% with a 95% confidence interval (0.719-0.797). Also, ROC is 
significantly different from 0.5 since P value (Asymptotic Significance) is < 0.05 meaning that the proposed 
predictive model has predicted the group significantly better than by chance.  
6. Conclusion  
This paper is presented a model to predict the probability of liver’s disease occurrence. The analysis and 
evaluation of the proposed model show that it is very efficient and easy to implement and use. The model 
provides high accuracy (72.4%), sensitivity (90.3 %) and specificity (78.3 %) as well as very good stability (0.758 
%). This makes the model suitable for use by the healthcare providers to facilitate the planning of timely 
intervention and also creates greater awareness of the risk of the disease. The predictive model also confirmed that 
laboratory tests such as (Age; Direct Bilirubin (DB), Alamine_Aminotransferase (SGPT), Total_Protiens (TP), 
Albumin (ALB)) were significant predictors of the categories of liver disease. Thus the model can be used by 
healthcare providers if they have the results of the conducted tests. It can be suggested for monitoring the progress 
of liver disease, for example, implementing as a tool for web-based and mobile phone. This study, however, has 
limitations of feasibility and resource constraints. The small size of the sample, for example, may be raised as 
limitations of the present study; the sample would be more representative if more information from liver patients 
are collected. In the future, therefore we aim to increase the number of patients as well as using various tests. 
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